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Tuberculosis (TB) in HIV-co-infected (HIV-TB) patients is 
characterised by high rates of smear-negative pulmonary and extra-
pulmonary disease, with increasing levels of antimycobacterial drug 
resistance and high rates of co-morbid opportunistic infections 
(OIs).1,2 Difficulty in making the diagnosis of TB in HIV-infected 
patients results in diagnostic delay and the need for increased 
hospital admission. Prior to the HIV era, South Africa’s district 
hospitals that offered specialist TB services generally housed patients 
who were unable to mobilise and care for themselves or who required 
enhanced adherence monitoring, drug rechallenge for toxicity, or 
treatment for drug-resistant TB. At Brooklyn Chest Hospital (BCH), 
a district-level hospital offering specialist TB services in Cape Town, 
we have observed an increase in the complexity and severity of illness 
in HIV-TB patients in the HIV era.
Anecdotal experience suggests that this complexity is in part due 
to mycobacteriologically unconfirmed TB, HIV-related comorbidity 
such as opportunistic processes or organ-specific damage due to the 
virus itself, and increasing case numbers of drug-resistant TB. In our 
experience, these patients commonly require upreferral to secondary- 
and tertiary-level services because, in part, of lack of training and 
specialised radiology services at the hospital. To investigate the 
complexity of patients at BCH, we performed a cross-sectional study 
to document patient types housed at BCH, their co-morbidities and 
their requirement for up-referral to other institutions.
Study population and methods
BCH comprises 271 adult and 56 paediatric beds. Patients receive 
inpatient care for TB and HIV care on-site. The highest staffing grade 
to oversee day-to-day care of patients is a medical officer. On-site 
radiological services are limited to plain X-rays; no computerised 
tomography or ultrasound is available. The Divisions of Infectious 
Diseases and Pulmonology from the Department of Medicine, 
Groote Schuur Hospital (a tertiary hospital), have provided specialist 
input and support to adult patients.
Adult beds are divided into short-stay drug-sensitive, and long-
stay drug-resistant, wards, the latter housing patients with multi-
drug-resistant (MDR-TB), extensively drug-resistant (XDR-TB) and 
pre-XDR TB (patients with M. tuberculosis isolates that are resistant 
to rifampicin, isoniazid and either a fluoroquinolone or one of 
the injectable agents amikacin or kanamycin, but not yet to both 
fluoroquinolones and injectables).
We included all adult patients resident at BCH between 27 and 30 
October 2008. Their case records were reviewed at the bedside by 
an infectious diseases specialist (HvdP). The following parameters 
were recorded: age, gender, duration of stay, site of TB infection, 
bacteriological confirmation of TB diagnosis, antimycobacterial drug 
susceptibility pattern, HIV status (if HIV-infected, use of antiretroviral 
therapy (ART) and presence of other OIs were recorded), acute or 
chronic co-morbidity, Karnofsky performance score, and the need 
for specialist referral or investigation not offered on-site during 
their hospital stay. Stata version 10 was used for statistical analysis. 
For comparative proportions Fisher’s exact test, and for comparative 
means Student’s t-test, were used.
TB was treated as per national policy.3,4 On-site initiation of ART 
was introduced 6 months before the start of this study. The study was 
approved by the University of Cape Town’s Faculty of Health Sciences 
Research Ethics Committee.
Results
A total of 244 patients were entered (Table I): 102 drug-sensitive 
ward patients and 142 in drug-resistant wards. Drug-sensitive ward 
patients had high rates (71%) of HIV co-infection, low Karnofsky 
performance scores (60% qualifying as ‘severely disabled’ or worse 
i.e. Karnofsky score ≤30) and almost invariably (98%) had significant 
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Objectives. To define the patient population at Cape Town’s 
district-level hospital offering specialist tuberculosis (TB) services, 
concerning the noted increase in complex, sick HIV-TB co-infected 
patients requiring increased levels of care.
Methods. A cross-sectional study of all hospitalised adult patients 
in Brooklyn Chest Hospital (a district-level hospital offering 
specialist TB services) from 27 to 30 October 2008. Outcome 
measures were: type of TB and drug sensitivity, HIV co-infection, 
comorbidity, Karnofsky performance score, and frequency and 
reason for referral to other health care facilities.
Results. More than two-thirds of patients in the acute wards were 
HIV-co-infected, of whom 98% had significant comorbidities and 
60% had a Karnofsky performance score ≤30. Twenty-eight per cent 
of patients did not have a confirmed diagnosis of TB. In contrast, 
long-stay patients with multidrug-resistant (MDR), pre-extensively 
(pre-XDR) and extensively drug-resistant (XDR) TB had a lower 
prevalence of HIV co-infection, but manifested high rates of 
comorbidity. Overall, one-fifth of patients required up-referral to 
higher levels of care.
Conclusions. District-level hospitals such as Brooklyn Chest 
Hospital that offer specialist TB services share the increasing 
burden of complex, sick, largely HIV-co-infected TB patients with 
their secondary and tertiary level counterparts. To support these 
hospitals effectively, outreach, skills transfer through training, and 
improved radiology resources are required to optimise patient care.
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related to advanced HIV infection (Tables I and II). Thirty per cent 
of drug-sensitive ward patients were on empiric anti-TB therapy with 
an unconfirmed diagnosis of TB. The diagnosis of TB was made on 
culture in 71 patients, 43 of whom had first-line drug susceptibility 
testing (DST) performed. In total, antimycobacterial drug-resistance 
to rifampicin was documented in 16 of the 43 patients who had DST 
done on the drug-sensitive wards.
In contrast to the drug-sensitive wards, the complexity of 
patients housed in the drug-resistant wards related largely to 
antimycobacterial drug-resistance, including 60% with either 
pre-XDR-TB or XDR-TB (Table I). Unlike drug-sensitive ward 
patients, where nearly half had disseminated tuberculosis, the 
overwhelming majority in the drug-resistant wards had pulmonary 
disease (96%). HIV co-infection was present in 45 of 131 (34%) 
patients who had their HIV serostatus recorded. Patients had better 
Karnofsky performance scores (only 3% being classified as ‘severely 
disabled’); however, significant comorbidity was recorded in 72% 
of patients who had one or more additional diagnoses requiring 
active management (Table III). Severe bronchietasis and drug-
related toxicity were common, whereas comorbid OIs featured less 
prominently than in drug-sensitive ward patients, as fewer patients 
were HIV-co-infected.
Partly as a result of the rollout programme of ART to inpatients 
at BCH, 84/113 (74%) patients who were known to be HIV-infected 
were receiving ART, the majority having started as inpatients. 
The remainder of co-infected patients were enrolled into the ART 
treatment preparedness programme.
In total, 49 (20%) patients required referral to a higher level of 
care, the majority (69%) for imaging studies by either abdominal 
ultrasound or CT scan (Table IV).
Discussion
Patients in the drug-sensitive wards of Cape Town’s district level, 
specialist tuberculosis referral hospital are predominantly sick, 
bed-bound, and HIV-co-infected; 98% of them have complicating 
comorbid infections and non-infectious conditions. Patients 
in the drug-resistant, long-stay wards have equally high levels 
of comorbidity, but less HIV co-infection. As testimony to the 
complexity of diagnosing HIV-TB, almost one-third of acute ward 
residents in this TB referral centre had not had their diagnosis of TB 
confirmed and were on empiric therapy. This figure is higher than 
the 15% of unconfirmed cases previously reported from the same 
hospital in 2003.5 In addition, Thanassi et al. documented an MDR-
TB rate of only 16% in BCH among 434 inpatients over a 6-month 
period during 2000, compared with the rate of 58% reported in this 
study. Furthermore, as pre-XDR-TB and XDR-TB are newly defined 
sub-categories of drug-resistant TB, the overall rate of drug resistance 
in patients managed at BCH in 2008 has increased significantly. 
We also found a considerable need for up-referral to higher levels 
of care, predominantly for radiographic imaging that could have 
Table I. Characteristics of patients admitted to drug-sensitive and drug-resistant wards
Drug-sensitive wards
(N=102)
Drug-resistant wards
(N=142) p value
Female (%) 53 (52) 85 (60) 0.240
Median age (years) (IQR) 35 (28 - 44.5) 36 (26 - 45) 0.644
Mean length of stay (days) (range) 51 (2 - 236) 127 (1 - 602) <0.001
Site of tuberculosis (%)
   Pulmonary
   Disseminated
57 (56)
45 (44)
136 (96)
6 (4)
<0.001
Unconfirmed TB (%) 31 (30) 0 <0.001
Unknown drug susceptibility (%) 59 (58) 0 <0.001
Drug resistance (%)
   INH mono-resistance
   Rif  mono-resistance
   MDR-TB
   Pre-XDR-TB
   XDR-TB
22/43* (51)
6 (27)
16 (72)
0
0
0
142 (100)
0
0
57 (40)
48 (34)
37 (26)
<0.001
Number of patients HIV tested
   HIV-infected
   HIV-negative
   HIV status unknown
96
68 (71)
28 (29)
6 (6)
131
45 (34)
86 (66)
11 (8)
<0.001
Antiretroviral therapy
   Receiving ART (%)
   Awaiting ART (%)
44 (65)
24 (35)
40 (89)
5 (11)
0.004
Comorbidity (%) 98 (97) 102 (72) <0.001
Karnofsky performance score 
   Median (IQR)
   % with KPS ≤30
30 (30-40)
60
60 (50-70)
3
<0.001
*43 out of 71 cultured isolates had a known drug-susceptibility pattern.
Rif = rifampicin; INH = isoniazid; DST = drug susceptibility testing; ART = antiretroviral therapy; KPS = Karnofsky performance score.
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been performed on-site were facilities available. Movement of drug-
resistant TB patients to other facilities increases the potential for 
transmission of drug-resistant disease to HCWs and HIV-infected 
and -uninfected patients. Such movement of patients should be 
avoided wherever possible. Furthermore, ensuring that drug-sensitive 
and drug-resistant patients are managed in separate wards, while 
different categories of drug-resistant patients (MDR, pre-XDR and 
XDR) are also separated, is critical to prevent acquisition of a more 
resistant strain in hospital.6 The fact that 39% of patients with culture-
proven TB in the acute wards had not had drug-susceptibility testing 
performed is cause for concern. We believe that drug susceptibility 
testing should be performed on all patients admitted to TB hospitals 
in South Africa.
The profile of patients in BCH’s acute wards is little different 
to that of TB inpatients at Groote Schuur Hospital, which is the 
central academic hospital supporting this primary-level facility 
(Mendelson M, unpublished observations). The high level of HIV-
related comorbidity is a reflection of continued late presentation 
of HIV patients, in addition to the compounding problems of 
TB-immune reconstitution inflammatory syndrome (TB-IRIS),7 
shared drug toxicities between antiretrovirals and antimycobacterials, 
and malabsorption of drugs in wasted, cachexic patients. The 
pressure on bed occupancy at tertiary and secondary level health 
facilities directly affects the duration of sick patients at higher levels 
of care, necessitating the transfer of some TB patients to district level 
hospitals prior to stabilisation. High death rates in HIV-TB patients 
are commonly due to other HIV-related conditions, particularly OIs,8 
and managing such complex patients in facilities with medical officers 
that are inexperienced in managing HIV-related infections other than 
tuberculosis is a challenge faced by most specialist TB hospitals 
Table II. Comorbid conditions in TB patients admitted to 
drug-sensitive wards at BCH (N=170)*
HIV-associated conditions
WHO Stage 4 defining opportunistic infections
HIV-associated dementia
TB immune reconstitution inflammatory syndrome
26
7
4
Infections
Bacterial sepsis
Other infections
7
10
Respiratory
 Complicated pleural disease: empyema,  
intercostal drains
Severe bronchiectasis
Severe chronic obstructive pulmonary disease
Cor pulmonale
12
8
2
4
Neurological
Delirium/acute confusional state
Hydrocephalus
Stroke
Severe peripheral neuropathy
Seizures/epilepsy
6
5
4
6
4
Psychiatric
Alcoholism/substance abuse
Schizophrenia
Depression
15
3
2
Miscellaneous
Drug-induced hepatitis
Deep-vein thrombosis
Renal failure
Pressure sores
Hypertension
Diabetes mellitus
10
10
7
7
6
5
*Some patients had several comorbidities.
Table III. Comorbid conditions of TB patients admitted to 
drug-resistant wards at BCH (N=126)*
HIV-associated conditions
WHO Stage 4 defining opportunistic infections
HIV-associated dementia
TB immune reconstitution inflammatory syndrome
4
1
1
Infections
Bacterial sepsis
Other infections
3
6
Respiratory
Severe bronchiectasis
 Complicated pleural disease: empyema, intercostal 
drains
Severe chronic obstructive pulmonary disease
Other, e.g. major haemoptysis, bronchus Ca
24
2
1
2
Neurological
Delirium/acute confusional state
Stroke
Severe peripheral neuropathy
Epilepsy
Cerebral palsy
2
4
7
1
1
Psychiatric
Alcoholism/substance abuse
Schizophrenia
Depression
Acute psychosis
6
4
5
2
Drug-induced complications
Significant hearing impairment
Acute renal failure (drug-induced)
Cutaneous drug reaction
Drug-induced hepatitis
Hypothyroidism owing to para-aminosalicylic acid
12
3
3
1
3
Miscellaneous
Diabetes mellitus
Deep-vein thrombosis
Hypertension
Vasculitis
Arthritis
 Miscellaneous (fractures, blood dyscrasia, chronic  
otitis media)
Pressure sores
12
3
3
2
3
4
1
*Some patients had several comorbidities.
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in South Africa. The increased awareness of drug resistance as a 
developing problem and the resulting increase in sensitivity testing of 
M. tuberculosis isolates by provincial programmes both for 1st- and 
2nd-line drug sensitivity has resulted in an increase in the number 
of drug-resistant TB cases being identified. As it is mandatory for all 
pre-XDR-TB and XDR-TB patients to undergo inpatient treatment, 
this situation is leading to an increase in the number of drug-resistant 
TB cases managed at BCH and other specialist TB centres.
This study is limited in that it is a single time-point study. 
Nevertheless, it highlights the complexity and severity of patients 
admitted to a district-level hospital with specialist TB services in 
South Africa, whose patients are cared for by medical officers with 
limited training in HIV medicine. Outreach to these hospitals by 
physicians trained in infectious diseases and HIV medicine to 
support patient care and transferring skills to the resident staff is 
needed in all but a few hospitals that already have trained staff. As a 
result of this study, an outreach programme has been running at BCH 
since October 2008.
Our findings highlight infection prevention and control as a 
further cause for concern. Movement of patients with drug-resistant 
TB between health institutions should be avoided wherever possible. 
Rolling out ART on-site at BCH drastically reduced the movement 
of TB patients from the hospital to peripheral HIV clinics, thereby 
reducing the chance of TB transmission to susceptible patients. 
The finding that many of the referrals to higher levels of care 
were initiated by ultrasound or CT scans, suggests that increasing 
radiological resources at the hospital would reduce the need for 
transfer and potentially prevent nosocomial transmission of drug-
resistant TB. Furthermore, increasing outreach by specialist services 
such as psychiatry and infectious diseases from higher levels of care 
would further support resident staff and patients, while reducing the 
need for up-referral to other health care facilities.
With bed shortages and pressure on secondary- and tertiary-
level hospitals owing to the high burden of HIV and TB in South 
Africa, the continued admission of patients that do not have a 
confirmed diagnosis of TB to these hospitals remains a problem. As 
highlighted by Thanassi et al., such patients are less likely to transmit 
M. tuberculosis and they occupy hospital beds that are earmarked 
specifically for TB patients.5 Training resident staff in infectious 
diseases through improved outreach programmes helps to identify 
such patients and enables relocation to more appropriate facilities, 
thereby increasing the number of beds for bona fide TB patients.
In conclusion: BCH, a district-level hospital providing specialist 
TB services, and one of many throughout South Africa, houses 
sick, complex, acute patients with multiple co-morbidities, who 
commonly require up-referral to higher levels of care for imaging 
and consultation services that could be easily posititioned at this type 
of facility. The increasing burden of drug-resistant TB is equally felt 
at BCH and also associated with a high frequency of co-morbidity 
that complicates patient care. Outreach and skills transfer from 
secondary- and tertiary-level physicians is an important component 
to support district level hospitals that provide specialist TB services 
in South Africa.
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Table IV. Number of patients referred for higher level of care, 
and type of service required
Drug-sensitive 
wards
N=102 (%)
Drug-resistant 
wards
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Number of patients up-referred
Secondary level
Tertiary level
29 (28)
12 (41)
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20 (14)
11 (55)
9 (45)
Reason for referral*
Imaging
Specialist opinion
23/29 (79)
17/29 (59)
11/20 (55)
12/20 (60)
*Some patients who required imaging, also required a specialist opinion.
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